214 related articles for article (PubMed ID: 24217543)
1. Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDG.
Jain S; Sharma P; Dhull VS; Bal C; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):358-9. PubMed ID: 24217543
[TBL] [Abstract][Full Text] [Related]
2. A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT.
Treglia G; Salomone E; Petrone G; Giaccari A; Rindi G; Rufini V
Clin Nucl Med; 2013 Jul; 38(7):e306-8. PubMed ID: 23486330
[TBL] [Abstract][Full Text] [Related]
3. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
4. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
6. 68Ga DOTANOC PET/CT in primary neuroendocrine tumor of the breast.
Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):396-8. PubMed ID: 24566407
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at
Ruuska T; Ramírez Escalante Y; Vaittinen S; Gardberg M; Kiviniemi A; Marjamäki P; Kemppainen J; Jyrkkiö S; Minn H
Acta Oncol; 2018 Feb; 57(2):283-289. PubMed ID: 28686510
[TBL] [Abstract][Full Text] [Related]
8. Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT.
Treglia G; Cardillo G; Stefanelli A; Di Franco D; Enang GN; Giordano A; Rufini V
Clin Nucl Med; 2013 Dec; 38(12):e458-62. PubMed ID: 23486329
[TBL] [Abstract][Full Text] [Related]
9. The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.
Hindié E
Theranostics; 2017; 7(5):1159-1163. PubMed ID: 28435455
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor.
Sharma P; Naswa N; Kc SS; Alvarado LA; Dwivedi AK; Yadav Y; Kumar R; Ammini AC; Bal C
Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2194-202. PubMed ID: 25030618
[TBL] [Abstract][Full Text] [Related]
11. FDG DOTANOC Mismatch in In Vivo Characterization and Grading of Neuroendocrine Tumor.
Mukherjee A; Agarwal KK; Bal C; Kumar R
Clin Nucl Med; 2016 Dec; 41(12):e511-e513. PubMed ID: 27749422
[TBL] [Abstract][Full Text] [Related]
12. When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?
Fuccio C; Musto A; Cambioli S; Castellucci P; Pantaleo MA; Nanni C; Montini GC; Campana D; Tomassetti P; Bellan E; Massaro A; Grassetto G; Rubello D; Fanti S
Clin Nucl Med; 2011 Dec; 36(12):1109-11. PubMed ID: 22064082
[No Abstract] [Full Text] [Related]
13. Rare case of gall bladder neuroendocrine tumor: ¹⁸F-FDG and ⁶⁸Ga-DOTANOC PET/CT findings.
Chakraborty PS; Dhull VS; Karunanithi S; Roy SG; Kumar R
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):316-7. PubMed ID: 25043774
[No Abstract] [Full Text] [Related]
14. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ
Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518
[TBL] [Abstract][Full Text] [Related]
15. A rare case of synchronous bilateral pulmonary neuroendocrine tumor detected by 68Ga-DOTANOC PET/CT.
Taralli S; Treglia G; Perotti G; Graziano P; Cardillo G; Castaldi P; Calcagni ML; Rufini V; Giordano A
Clin Nucl Med; 2012 Apr; 37(4):e91-4. PubMed ID: 22391733
[No Abstract] [Full Text] [Related]
16. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
17. The role of combined Ga-DOTANOC and (18)FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors.
Partelli S; Rinzivillo M; Maurizi A; Panzuto F; Salgarello M; Polenta V; Delle Fave G; Falconi M
Neuroendocrinology; 2014; 100(4):293-9. PubMed ID: 25301162
[TBL] [Abstract][Full Text] [Related]
18. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor expressing bilateral ovarian metastases detected by (68)Ga DOTANOC PET/CT.
Arora S; Soundararajan R; Joshi P; Kumar R; Bal C
Clin Nucl Med; 2015 Jun; 40(6):496-8. PubMed ID: 25546200
[TBL] [Abstract][Full Text] [Related]
20. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
